Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2026-03-12 @ 7:48 PM
Study NCT ID:
NCT03081858
Status:
COMPLETED
Last Update Posted:
2025-06-27
First Post:
2017-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Sponsor:
Lipac Oncology LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Bladder Cancer Cell Transitional | View |
| None | Non-Muscle Invasive Bladder Cancer | View |
| None | Bladder Cancer | View |
| None | Urinary Bladder | View |
| None | Transitional Cell Carcinoma of the Bladder | View |
| None | Urinary Bladder Neoplasms | View |
| None | Urologic Neoplasms | View |
| None | Urogenital Neoplasms | View |
| None | Urinary Bladder Diseases | View |
| None | Urologic Diseases | View |